Clinical Trials During COVID-19


This video lecture discusses the impact of COVID-19 on clinical trials,  potential pathways and modifications needed to run a successful trial and how new technologies can assist in moving forward.

  • Session: year 2020
  • Course Type: Video Lessons
  • Language: English
  • Level: Intermediate
  • Time: 0 - 1 Hour


Section Time
Course introduction 00:00:08
Additional resources 00:00:05
Research Continuity During COVID-19 00:00:49
Speakers 00:00:41
Impact On Clinical Trials 00:00:25
Major Disruption 00:00:50
EMA: Who They Are 00:00:48
EMA Regulatory Guidance 00:01:18
MHRA: Who They Are 00:00:58
MHRA Regulatory Guidance 00:02:46
FDA: Who They Are 00:00:51
FDA Regulatory Guidance 00:01:52
Regulatory guidance summarized – pt. 1 00:00:43
Regulatory guidance summarized – pt. 2 00:00:35
Trial Assessment 00:00:39
Tiered Approach 00:00:31
If continued enrollment or engagement is required 00:01:00
If the trial will be halted 00:00:31
In Any Scenario 00:00:20
Thinking in and outside the box – pt. 1 00:00:51
Thinking in and outside the box – pt. 2 00:00:39
Assessing tools and suppliers 00:01:06
How Meditrial Fits In 00:01:20
What meditrial is doing in the COVID-19 fight – pt. 1 00:00:59
What meditrial is doing in the COVID-19 fight – pt. 2 00:01:18


What I will learn?

In this course, we discuss the struggles of conducting a clinical trial during the COVID-19 pandemic, getting know the key guidance released by Competent Authorities.

Skills I will gain

  • You will find out how to do a risk assessment of your trial, considering the participants safety
  • You will gain insight on the regulatory guidance created by EMA, MHRA and FDA especially for trials during this       pandemic
  • You will learn how to use technology to your advantage (remote monitoring, enrollment, informed consent)


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Go to Top